Murphy Samuel Lafayette

Murphy Samuel Lafayette is listed in filings as Director at Viracta Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 24, 2024, including 1 public disclosure. Recent filings connect the profile to Viracta Therapeutics, Inc. (VIRX). The current snapshot covers public activity from Jun 24, 2024. Reported amounts are shown as $28.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.